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This longitudinal and prospective study analyzes the ability of orbital blood flow measured by color Doppler imaging (CDI)
to predict glaucoma progression in patients with glaucoma risk factors. Patients with normal perimetry but having glaucoma
risk factors and patients in the initial phase of glaucoma were prospectively included in the study and divided, after a five-year
follow-up, into two groups: “Progression” and “No Progression” based on the changes in the Moorfields regression analysis (MRA)
classification of Heidelberg retina tomograph (HRT). An orbital CDI was performed in all patients and the parameters obtained
were correlated with changes in HRT. A logistic discrimination function (LDF) was calculated for ophthalmic artery (OA) and
central retinal artery (CRA) parameters. Receiver operating characteristics curves (ROC) were used to assess the usefulness of
LDFs to predict glaucomatous progression. A total of 71 eyes were included. End-diastolic velocity, time-averaged velocity, and
resistive index in the OA and CRA were significantly different (𝑃 < 0.05) between the Progression and No Progression groups.The
area under the ROC curves calculated for both LDFs was of 0.695 (OA) and 0.624 (CRA). More studies are needed to evaluate the
ability of CDI to perform early diagnosis and to predict progression in glaucoma in eyes.
1. Introduction
Ultrasound is a classic diagnostic tool for the morphologic
evaluation of ophthalmic pathology [1, 2]. The ability of
Doppler ultrasound to obtain quantitative measurements of
vascular flow opens up a new range of diagnostic possibilities,
allowing statistical analysis, with a greater degree of diag-
nostic discrimination in pathologies such as glaucoma whose
pathophysiology seems to involve vascular factors [3–5].
Primary open angle glaucoma, according to the World
Health Organization (WHO), is currently the most frequent
cause of preventable irreversible blindness in the world
[6, 7]. It is caused by optic neuropathy characterized by
acquired irreversible loss of retinal nerve fibers that comprise
the optic nerve (ON). Glaucoma axonal loss occurs years
before noticeable alterations of the visual field (VF) are
detected [8, 9]. Once the alterations occur, VF loss is irre-
versible; therefore, early diagnosis of glaucoma is critical for
preventing progressive vision loss.
Glaucomatous injury is insidious and difficult to struc-
turally recognize until advanced disease is already present
due to the wide range of normal variations in the optic papilla
and the retinal nerve fiber layer (RNFL). The fact that the
ON head perfusion is directly related to retrobulbar circu-
lation [10, 11] that is directly accessible to ultrasound study
makes color Doppler imaging (CDI) a potential tool for
the evaluation of early changes in vascular flow related to
glaucoma. The use of CDI has been validated already in
the evaluation of moderate and advanced glaucoma patients,
consistently detecting flow velocity alterations and increased
resistive index in these patients in comparison with healthy
controls [12–17]. Nevertheless, CDI value as a tool for early
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glaucoma diagnosis and progression has not been systemati-
cally studied. To our knowledge, only Calvo et al. [18] have
included glaucoma suspects or early glaucoma patients. In
both studies, the orbital CDI parameters have been corre-
lated with glaucoma development or progression based on
structural criteria (Heidelberg Retina Tomograph version 3,
HRT3) periodically determined over a long period. We also
have performed a logistic discrimination function (LDF) to
predict progression using ophthalmic artery (OA) and central
retinal artery (CRA) parameters. Zeitz et al. [19] andMart´ınez
and Sa´nchez [20] studied CDI value predicting glaucoma
progression including established glaucoma patients. In both
studies themethods used to determine glaucoma progression
were cup-to-disc ratio in conjunctionwithVF testing [19] and
with VF changes [20].
The primary objective of our study was to analyze in
a group of patients with glaucomatous risk factors possible
differences in orbital blood flow (OBF) measured by CDI,
between patients who remained stable and those who pro-
gressed. Secondarily we investigated which ocular vascular
structures are most sensible to detect progression and pos-
sible modifications of flow patterns associated with major
changes and their diagnostic value.
2. Methods and Materials
A 5-year prospective longitudinal study was designed to
analyze the possible OBF changes detected by CDI in glau-
coma risk patients and in an early stage of glaucoma. The
protocol followed the tenets of the Declaration of Helsinki
for biomedical research andwas approved by the Institutional
Review Board of our hospital, and a written consent was
obtained from all participants.
2.1. Patients. The study included patients with normal stan-
dard automated perimetry (SAP) but having glaucoma risk
factors based on the features of the papilla (as determined
by clinical assessment of the optic nerve head (ONH); see
definition below), or the presence of ocular hypertension
(≥21mmHg), and patients in the initial phase of the disease
with discretely altered SAP (mean deviation (MD) less than
−5 dB) [21]. Patients were prospectively recruited as part
of ongoing studies within the “Early Glaucoma Diagnosis
Program,” a prospective longitudinal study designed to eval-
uate optic nerve structure and visual function in glaucoma,
conducted at our hospital.
Inclusion criteria were refractive error of less than 5
spherical diopters and 2 diopters cylinder, open anterior
chamber angle, transparent ocular media, and best-corrected
visual acuity of 20/40 or better. Exclusion criteriawere history
of ocular or neurologic disease, intraocular surgery within 3
months before enrollment in the study or through the follow-
up period, diabetes, and current use of a medication that
could affect visual field sensitivity such as corticosteroids,
antirheumatic drugs (quinolines, indomethacin, and allop-
urinol), psychiatric drugs (phenothiazine, thioridazine, and
chlorpromazine), and drugs used in cardiology (practolol,
amiodarone, and digitalis glycosides).
2.2. Study Protocol. Participants underwent an ophthalmo-
logic examination that included clinical history, biomi-
croscopy of the anterior segment by a slit lamp, visual acuity,
gonioscopy, ultrasonic pachymetry, ophthalmoscopy of the
posterior segment, Goldmann applanation tonometry, and at
least two reliable standard automated VF tests. To define the
glaucomatous risk factors based on the features of the papilla,
the ONH was clinically assessed in all subjects by evaluating
simultaneous stereophotographs of the optic disc. Clinical
assessment of the ONH was performed after mydriasis (0.5%
tropicamide; Alcon Laboratories Inc., Fort Worth, TX) by
evaluating stereophotographs of the optic disc (Canon CF-
60UV fundus camera; Canon Inc., Tokyo, Japan). The pho-
tographs were evaluated by two glaucoma specialists (A. F.
and L. P.) blinded to the patients’ identity and clinical history.
Glaucomatous optic disc morphology was defined as diffuse
neuroretinal rim narrowing with concentric enlargement of
the optic cup, localized notching, or both. Any disagreement
was resolved by consensus.
Topographic analysis of the ONH was performed using
a confocal scanning laser ophthalmoscope, the HRT3 (Hei-
delberg Engineering, Heidelberg, Germany).The HRT3 soft-
ware displays several windows in which the topographic
results are detailed; one of them, the Moorfields regression
analysis (MRA) classification [22, 23], compares the rim area
with the predicted rim area for a given disc area and age,
based on confidence limits of a regression analysis derived
from an internal database. The optic disc is divided into 6
color-coded sectors (nasal superior, temporal superior, nasal
inferior, temporal inferior, nasal, and temporal), and each
sector is classified as “within normal limits” if the percentage
of the rim falls within the 95% confidence interval (CI)
(represented in green), “borderline” if the percentage of the
rim is between 95% and 99.9%CI (represented in yellow), and
“outside normal limits” if the result is greater than 99.9% CI
(represented in red).
OBF velocities of retrobulbar vessels were measured by
color Doppler imaging at the beginning of the follow-up in
all eyes. All the US examinations were performed with the
same commercially available equipment (Siemens Sonoline
Sienna, Erlangen, Germany) with a 7.5MHz linear phased-
array transducer. The same trained radiologist (F. J.) per-
formed all tests. All subjects were examined in the supine
position with the US probe gently placed on the closed upper
eyelid taking care to minimize pressure on the globe, using
a coupling gel. The ultrasound study began with a B-mode
morphologic evaluation of the ocular structures in order to
exclude the presence of concomitant injuries and to locate, in
the conal region, the hypoechoic central band corresponding
to ON, the reference place for the Doppler study of the ocular
vessels (Figure 1).
Later, CDI hemodynamic measurements of the OA,
CRA, and the short posterior ciliary arteries (SPCAs) were
obtained.TheOAwas studied in its nasal portion with regard
to ON; CRA was identified next to central retinal vein as two
parallel vascular structures with opposite flow sense included
in the hypoechoic central band of the conal region; SPCAs
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Figure 1: Transverse gray-scale US image that shows normal anatomy of ocular structures: anterior chamber (1), lens (2), vitreous body (3),
in the conal region, the hypoechoic central band (4) corresponding to optic nerve sheath complex, and the retrobulbar fat (5).
were visualized in the posterolateral region of the papilla, on
both sides, temporal and nasal, respectively (Figure 2).
Correction of the insonation angle was performed when
the axis of the studied vessel was not enough aligned with
the ultrasound beam, mainly in the ciliary arteries. The
parameters evaluated included arterial peak systolic velocity
(PSV), end-diastolic velocity (EDV), time-averaged velocity
(TAV), resistive index [RI = (PSV − EDV)/PSV], pulsatility
index (PI) [PI = (PSV − EDV)/TAV], and the relation sys-
tole/diastole (S/D) (S/D = PSV/EDV) [24, 25]. The operator
was blinded to the results of all ophthalmology tests and the
condition of each eye.
2.3. Classification into Groups and Follow-Up
(a) Progression and No-Progression Groups Based on Topo-
graphic Criteria. Patients were followed up for at least 5 years,
with a minimum of once yearly reliable HRT3 examination.
Conversion to glaucoma or progression was defined by a
change of at least 3 sectors (from within normal limits to
borderline, from borderline to outside normal limits, or from
normal to outside normal limits) in the color-coded MRA
classification at any moment during the 5 years of follow-up
[26, 27]. Because the temporal and nasal sectors are generally
less sensitive for detecting glaucomatous changes [23, 28],
they were excluded from the statistical analysis.
As the sample included subjects with glaucoma risk
factors but without damage as assessed by SAP as well as
glaucoma patients with slightly altered SAP, the concept
“glaucoma progression” included progression from no glau-
coma damage to a certain grade of glaucoma and also from
low-grade glaucoma to high-grade glaucoma. During follow-
up time, each patient was treated at the discretion of the
attending ophthalmologist.
(b) Patient Classification Based on Perimetry and Glaucoma
Risk Factors. The sample was divided into three groups based
on the VF, intraocular pressure, and the aspect of the papilla.
These three groups were composed of
(1) only patients with initial perimetric glaucoma,
(2) patients with normal perimetry that were divided
into two groups: patients with normal ONH but with
intraocular hypertension and patients with normal
intraocular pressure but with glaucomatous ONH.
The baseline characteristics of these two groups were
analyzed separately.
2.4. Statistical Analysis. All statistical analyses were per-
formed using the IBM Statistical Package for the Social Sci-
ences (SPSS 17.0, SPSS Inc., Chicago, IL, USA) and MedCalc
(version 9.3 MedCalc Software, Belgium) statistical software.
The Kolmogorov-Smirnov test was used to assess sample dis-
tribution. Because of the nonparametric distribution of data,
differences between groups of patients were compared using
the Mann-Whitney U test or ANOVA test for comparison of
two or three variables, respectively. Chi-square test was used
to compare qualitative categorical variables between both
groups. Values of 𝑃 < 0.05 were considered to be indicative
of statistically significant differences.
The relative importance of each independent variable
was assessed by stepwise binary logistic regression analysis
using the forwardWaldmethod.TheWald chi-square statistic
tested the unique contribution of each independent variable
(predictor variable), in the context of the other predictors
(holding constant the other predictors), eliminating any
overlap between them. In this study, the dependent variable
was whether a patient glaucoma progressed or not, and the
independent variables were PSV, EDV, TAV, RI, PI, and S/D
for each artery. The significant parameters of the Doppler US
study for each artery then were combined to generate a new
variable, the logistic discrimination function (LDF), a score
formed by taking a weighted sum of the predictor variables as
LDF = 𝑎−𝑏×𝑐, where 𝑎 is a constant of the model influences
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Figure 2: (a) Transverse color Doppler image that demonstrates the location of the ophthalmic artery (OA), medial to the optic nerve (ON),
and the typical OA waveform obtained by pulsed Doppler that shows a sharp systolic peak, a dicrotic notch, and a relatively little flow in
diastole. (b) Transverse color Doppler image showing the central retinal artery (CRA) and central retinal vein (CEV) in the center of the ON.
The typical waveforms for central retinal vessels show the CRA curve above the zero axis (with rounded systolic peak and continuous flow
during diastole) and the CRV below the zero axis (with low and continuous flow). (c) Transverse color Doppler image that demonstrates the
posterior ciliary arteries (PCSAs) in the retrobulbar fat. The typical PCAs waveform obtained by pulsed Doppler shows a blunted systolic
peak and a low to moderate flow velocity during diastole.
by all the studied parameters and 𝑏 is the logistic regression
coefficient of the more significant parameter (𝑐).
The sensitivity and specificity of the LDF for each artery
to predict glaucomatous progression were evaluated using
receiver operating characteristics (ROC) curves. An area
under the ROC curve (AUC) of 1.0 represents perfect dis-
crimination, whereas an AUC of 0.5 represents chance dis-
crimination.
3. Results
A total of 95 eyes of 95 consecutive subjects who fulfilled
the inclusion criteria were prospectively preenrolled. Twenty-
eight patients were excluded from the study due to noncom-
pletion of required tests (17 patients), inability to perform
at least one of the tests included in the study protocol (5
patients), and not providing informed consent (2 patients).
Finally, 71 eyes from 71 patients of Caucasian origin were
included in the statistical analysis.
As defined above, according to the changes in the MRA
over the 5 years of follow-up, the sample was divided into
2 groups: Progression and No-Progression. The No-Progres-
sion group included 59 patients (83.1%), 24 males (40.67%)
and 35 females (59.32%), and the Progression group included
12 patients (16.9%), 3 males (25%) and 9 females (75%).
The clinical and demographic information of both groups at
baseline, including sex, age, mean intraocular pressure (IOP),
pachymetry (CCT), mean deviation of standard automated
perimetry (MD of SAP), pattern standard deviation (PSD)
of SAP and disc area, and vertical cup-to-disc ratio (C/D),
is showed in Table 1. No significant differences were found
between the two groups.
The clinical and demographic information was compared
between the two groups of patients with normal perimetry,
those with normal VF and normal ONH but with ocular
hypertension, and those with normal VF and ocular pressure
but with glaucomatous ONH. This information is shown in
Table 2. No significant differences were detected between the
two groups in age, sex, pachymetry, or perimetry. Significant
differences were observed between groups in IOP, which
is related to the classification criteria (first group included
patients with intraocular hypertension and the second one
included patients with normal IOP). The percentage of
patients that progressed in each group was similar.
The hemodynamic measurements obtained at CDI in the
Progression and No-Progression groups were compared, as
BioMed Research International 5
Table 1: Clinical and demographic information of both study groups, Progression and No-Progression; 𝑃 < 0.05 was considered statistically
significant.
Unit No progression Progression P
Number of eyes 59 12 n/a
Sex Male/female 24/35 3/9 0.546
Age Years (SD; range) 54.03 (8.911; 24–76) 55.75 (15.16; 27–71) 0.876
Mean IOP Hg mm (SD; range) 23.58 (1.50; 21–26) 22.22 (1.47; 21–25) 0.124
Pachymetry (CCT) 𝜇m (SD; range) 550.80 (38; 390–636) 532.42 (34.47; 465–596) 0.347
MD of SAP Decibels (SD; range) −1.79 (3.06; −17.37–1.35) −0.78 (0.77; −2.07–0.51) 0.656
PSD of SAP Decibels (SD; range) 2.22 (2; 0.92–12.81) 1.8 (0.69; 1.17–3.24) 0.076
C/D Mean (SD; range) 2.75 (0.92; 1–5) 3.92 (0.67; 3–5) 0.844
Spherical equivalent Diopters (SD; range) −0.56 (2.19; −3.97–2.81) −0.78 (2.37; −3.33–2.55) 0.396
IOP: intraocular pressure; CCT: central corneal thickness; MD of SAP: mean deviation of standard automated perimetry; PSD of SAP: pattern standard
deviation of standard automated perimetry; C/D: vertical cup-to-disc ratio in stereophotographs.
Table 2: Clinical and demographic information of both groups of normal perimetry patients.𝑃 < 0.05was considered statistically significant.
Patients with normal perimetry,
normal optic nerve head, and
intraocular hypertension
(𝑛 = 45)
Patients with normal perimetry,
glaucomatous optic nerve head,
and normal intraocular pressure
(𝑛 = 16)
P
Sex (male/female) 17/28 6/10 0.679
Mean age (years) 55.41 ± 13.5 53.98 ± 16.00 0.107
Mean IOP (Hg mm) 26.01 ± 10.43 14.98 ± 7.78 0.009
Mean Pachymetry (𝜇m) 543.21 ± 35.56 545.09 ± 32.33 0.254
MD of SAP (decibels) −1.55 ± 2.34 −1.12 ± 2.98 0.330
Progression in MRA during 5 years (𝑛) 9 3 0.412
IOP: intraocular pressure; MD of SAP: mean deviation of standard automated perimetry.
shown inTable 3. Significant differences between groupswere
found in the OA and CRA, on EDV, TAV, and RI (𝑃 < 0.05)
(Figure 3).
The OA and the CRA showed higher PSV and lesser PI
in the No-Progression group than in the Progression one; the
SPCAs showed higher flow velocities and lesser RI and PI in
No-Progression group; however, these differences were not
statistically significant.
As previously mentioned, statistically significant differ-
ences between the Progression and No-Progression groups
were found inOAandCRA, so an LDF that allowsmaximized
measurable differences between the groupswasmade for each
one. The most significant parameters of the CDI study for
each artery assessed by stepwise binary logistic regression
were combined to generate an LDF for each artery obtaining
OALDF 1.106 − 0.228 × AOTAV and ACRLDF = −5.102 +
2.114 × ACRPI.
The diagnostic capability of both LDFs was calculated
using ROC curves, obtaining an AUC of 0.695 for the OA
(95% confidence interval (CI): 0.571–0.801) (Figure 4(a)) and
0.624 (95% CI: 0.5–0.737) for CRA (Figure 4(b)), being
in both cases over 0.5. The comparison of both curves
(Figure 4(c)) showed cutoff points with a specificity of 90%
with a sensitivity of 54.55% in the OA and a specificity of 94%
with a sensitivity of 50% in the RCA.
As previously described, the sample was also divided
into groups based on perimetry and glaucoma risk factors,
independent of progression. The orbital CDI characteristics
of these groups were also compared and the results are shown
in Table 4. These groups comprised (1) patients with initial
perimetric glaucoma, (2) patientswith initial perimetric glau-
coma and those with normal VF and ONH but having ocular
hypertension, (3) the whole population. Flow velocities were
larger and resistance indices (RI, PI, and S/D) smaller in
the second group than in the other two groups. There were
no significant differences between groups, however, in any
hemodynamic parameter.
4. Discussion
The alteration in OBF dynamics is well recognized in glau-
coma. Many studies over the last twenty years have shown
that vascular factors may play an important role in glaucoma
pathogenesis due to an OBF autoregulation failure [3, 4].
Moreover, although elevated IOP is a well-known major risk
factor for glaucoma, it has been demonstrated that there are
numerous patients in whom glaucoma progressed despite
an IOP therapeutic reduction [29, 30], so IOP is a poor
progression marker. In the present study no significant
differences in IOP (registered at the beginning of the study)
were observed between glaucoma Progression and No-
Progression patients; however, significant differences were
found for some orbital CDI parameters between both groups.
A combination of decrease in flow velocities and increase
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Table 3: Comparison of hemodynamic parameters obtained at color Doppler imaging in Progression and No-Progression groups.
Doppler US parameter Unit Progression group No-Progression group P
OA
Ophthalmic artery
PSV cm/s (SD) 25.68 (9.9) 30.70 (8.14) 0.163
EDV cm/s (SD) 5.29 (2.83) 7.32 (3.01) 0.043
TAV cm/s (SD) 10.64 (5.34) 14.4 (4.70) 0.042
RI (SD) 0.79 (0.05) 0.75 (0.05) 0.038
PI (SD) 1.92 (0.58) 1.66 (0.33) 0.093
S/D (SD) 5.17 (1.32) 4.50 (1.15) 0.091
CRA
Central retinal artery
PSV cm/s (SD) 8.79 (2.92) 9.56 (2.31) 0.099
EDV cm/s (SD) 1.88 (0.54) 2.41 (0.84) 0.034
TAV cm/s (SD) 3.92 (1.28) 4.6 (1.25) 0.042
RI (SD) 0.77 (0.06) 0.73 (0.05) 0.043
PI (SD) 1.85 (0.59) 1.51 (0.29) 0.180
S/D (SD) 4.66 (1.51) 4.12 (1.03) 0.261
SPCAs
Short posterior ciliary arteries
PSV cm/s (SD) 15.12 (4.07) 16.32 (6.52) 0.914
EDV cm/s (SD) 4.32 (1.81) 4.90 (2.07) 0.349
TAV cm/s (SD) 8.24 (2.88) 8.47 (3.30) 0.994
RI (SD) 0.72 (0.08) 0.69 (0.06) 0.341
PI (SD) 1.40 (0.39) 1.12 (0.25) 0.457
S/D (SD) 3.90 (1.38) 3.43 (0.74) 0.618
Values are expressed as mean (standard deviation). Arterial evaluations included peak systolic velocity (PSV), end-diastolic velocity (EDV), time-averaged
velocity (TAV), resistive index (RI), pulsatility index (PI), and the relation systole/diastole (S/D). ∗Significant differences (𝑃 < 0.05) between both groups were
found in the OA and CRA, on FDV, TAV, and RI (in bold print).
(a) (b)
Figure 3: (a) Doppler frequency shift for the ophthalmic artery in the right eye of a patient that showed progression in the HRT-3 (peak
systolic velocity PSV = 34.9 cm/s, end-diastolic velocity EDV = 3.7 cm/s, time-averaged velocity TAV = 10.1 cm/s, resistive index RI = 0.89,
pulsatility index PI = 3.09, and the relation systole/diastole S/D = 9.43). (b) Doppler frequency shift for the central retinal artery in the right
eye of the same patient (PSV: 9.6 cm/s; FDV = 1.4 cm/s; TAV = 3.6 cm/s; S/D = 6.86; RI: 0.85; PI = 2.28).
in pulsatility and resistive indices obtained by orbital CDI,
was registered in progressing glaucoma patients compared
to those who remain stable. These results suggest that orbital
hemodynamics studied by CDI may represent an important
biomarker to discriminate glaucoma patients with higher
risk for progression. Doppler US may thus help to institute
a more aggressive clinical management in conflicting cases
with higher progression risk. Although the current data does
not allow us to establish hard velocity parameters to define
the threshold between normal and pathologic dynamics, it
does show a recognizable difference in the mean velocities of
the two groups, but with an overlap between the two patient
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Figure 4:The ROC curve shows the diagnostic capability of the LFD for ophthalmic artery (a) and central retinal artery (b).The comparison
between both ROC curves (c) shows best calculated cutoff points.
groups due to the wide range of measured values, which is
also typical of all other functional and structural glaucoma
tests currently available in clinical practice. However, Calvo
et al. [18] determined after a follow-up of 48 months that
an RI value higher than 0.75 in the OA was associated with
glaucoma progression in glaucoma suspects.
Doppler US has been recognized in many papers as an
effective tool to assess alteration in these flow dynamics
[12, 13, 15]. Most of published studies include healthy patients
without glaucoma risk factors as controls and patients with
well-established glaucomatous damage as cases, while our
population was performed by subjects with risk factors for
glaucoma, but without yet established visual field impairment
(<−5 dB of MD). Although this population selection may
exhibit less apparent differences in retrobulbar flow dynam-
ics, itmay validate better the usefulness ofDopplerUS in early
8 BioMed Research International
Table 4: Comparison of hemodynamic parameters obtained by color Doppler imaging in the following three groups: A—patients with
perimetric glaucoma, B—patients with perimetric glaucoma and patients with normal visual field and intraocular pressure but with
glaucomatous optic nerve head, and C—the whole study population.
Doppler US parameter Unit
Patients with
perimetric glaucoma
(𝑛 = 10)
Patients with perimetric glaucoma + patients
with normal VF and IOP but with
glaucomatous ONH (𝑛 = 55)
The whole
population
(𝑛 = 71)
P
OA
Ophthalmic artery
PSV cm/s (SD) 25.60 (10.21) 29.87 (8.79) 27.43 (9.12) 0.234
EDV cm/s (SD) 5.44 (2.92) 7.28 (2.89) 6.21 (2.77) 0.134
TAV cm/s (SD) 10.52 (5.10) 14.33 (4.81) 12.01 (5.01) 0.459
RI (SD) 0.78 (0.05) 0.76 (0.04) 0.77 (0.05) 0.501
PI (SD) 1.93 (0.48) 1.65 (0.37) 1.79 (0.40) 0.192
S/D (SD) 4.98 (1.28) 4.72 (1.21) 4.73 (1.22) 0.237
CRA
Central retinal artery
PSV cm/s (SD) 9.00 (2.67) 9.11 (2.44) 9.07 (2.52) 0.109
EDV cm/s (SD) 1.91 (0.63) 2.14 (0.62) 2.01 (0.62) 0.207
TAV cm/s (SD) 4.03 (1.26) 4.39 (1.27) 4.16 (1.27) 0.119
RI (SD) 0.76 (0.05) 0.74 (0.05) 0.75 (0.05) 0.096
PI (SD) 1.79 (0.50) 1.58 (0.32) 1.67 (0.37) 0.102
S/D (SD) 4.66 (1.40) 4.21 (1.29) 4.49 (1.33) 0.440
SPCAs
Short posterior ciliary arteries
PSV cm/s (SD) 15.54 (4.58) 15.96 (5.49) 15.87 (5.03) 0.450
EDV cm/s (SD) 4.50 (1.70) 4.70 (1.97) 4.62 (1.88) 0.691
TAV cm/s (SD) 8.37 (2.87) 8.45 (3.13) 8.43 (2.99) 0.409
RI (SD) 0.72 (0.07) 0.70 (0.08) 0.71 (0.07) 0.631
PI (SD) 1.37 (0.32) 1.20 (0.30) 1.26 (0.31) 0.422
S/D (SD) 3.88 (1.15) 3.61 (0.98) 3.69 (1.00) 0.702
Visual field (VF); intraocular pressure (IOP); optic nerve head (ONH); values are expressed as mean (standard deviation). Arterial evaluations included peak
systolic velocity (PSV), end-diastolic velocity (EDV), time-averaged velocity (TAV), resistive index (RI), pulsatility index (PI), and the relation systole/diastole
(S/D). ∗Significant differences (𝑃 < 0.05).
glaucoma diagnosis, which is very relevant in glaucoma to
prevent the irreversible damage of RNFL.
The orientation of the study towards early diagnosis of
glaucoma also influenced the diagnostic method used to
establish the subjects’ progression, opting for a structural
method, specifically theMRAOFHRT3, instead of perimetry
changes. Previous studies [31–33] demonstrated that optic
nerve or retinal nerve fiber layer damage precedes visual field
damage in glaucoma, so we used topographic analysis of the
optic nerve and retinal nerve fiber layer to determine progres-
sion in our sample.
Two of the six sectors in which the HRT3 divides the
papilla, the temporal and nasal sectors, have less sensitivity
for detecting glaucomatous changes [23, 28]. The superior
and inferior sectors of the ONH, however, have been used to
assess early signs of glaucoma progression [34, 35].This could
be related to the thicker retinal nerve fiber layer bundles in the
superior and inferior regions and the thinner bundles in the
temporal and nasal regions, which allows the HRT to more
easily detect and quantify changes in the vertical axis. Based
on these data and to improve accuracy and avoid bias, the
temporal and nasal sectors were excluded from the statistical
analysis.
As Plange et al. reported [15], we found higher flow
velocities and lesser RI and PI in SPCAs in the group of No-
Progression, but these differences were not statistically sig-
nificant. In contrast, there are some studies that show reduced
circulation in these vessels in patients with glaucoma [36–39],
and Zeitz et al. [19] found decreased blood flow velocities in
the SPCA associated with glaucoma progression. The small
caliber of these vessels avoid individual measurements, and
due to their direction, variable insonation angles are usually
required for their analysis. Furthermore, the wide variability
in their measurements is higher than in other vessels and has
been suggested previously [40–42]. On the other side, the
larger size and more accessible locations of the OA and the
CRAmake their measurements easier andmore reproducible
with Doppler US. Vascular supply of the external part of
the retina depends directly on the SPCA, branches of the
OA, making it therefore presumable that factors affecting the
flow parameters of OA and CRA may also similarly impact
the SPCA (whose direct demonstration is technically more
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difficult). For these reasons, we think that larger studies may
find significant alterations in the CDI parameters of SPCAs.
Other authors [16, 18] did not find differences between
patients with stable and deteriorating visual fields for the
CRA. The different designs and samples of the studies, as
well as the different techniques used, make comparison of
results difficult.We found significant differences in someCDI
parameters, as previous authors have reported. RI has some
advantages over other parameters because it includes systolic
and diastolic velocity values and is the most reproducible
parameter in Doppler ultrasound (coefficient of variation
around 6%) [36]. CDI is a noninvasivemethod that allows the
analysis of the vascular implications in glaucoma. The repro-
ducibility and accuracy of OBF measurements are variable
and depend on technique homogeneity and methodologic
design [41].
Thepurpose of the LDF for theOAandCRAwas to reflect
the best combination of CDI parameters that may differenti-
ate between stable and progressive glaucomatous patients and
predict glaucoma progression.
In the present study, both LDFs showed an AUC higher
than 50% (AUC of 0.695 for the OA and 0.624 for CRA).
Specificities of our LDFs ranged between 90% and 94%,
and sensitivity was 55%. This is a relatively poor diagnostic
ability, in part, due to the type of sample used to focus on
early diagnosis, where the onset of visual field loss was not
yet severe. A sample with more severe disease may have
provided increased sensitivity, as Plange et al. found in
glaucoma patients [12]. These results suggest that the use of
the proposed LDFs and orbital Doppler ultrasound should
be associated with other diagnostic methods to establish
glaucoma progression.The orbital hemodynamics studied by
CDI, however, seem to be a useful biomarker for predicting
the probability of glaucoma progression, especially for cases
with nonclassical behavior or in the early stages for whom the
results could lead to the adoption of more or less aggressive
therapeutic measures.
We must acknowledge some limitations of our study.
Orbital CDI was only assessed at the beginning of the
follow-up; however, other orbital CDI registers in the middle
and at the end of the study could correlate strongly the
association between orbital CDI and glaucoma progression.
The relationship between CDI and clinical characteristics was
also only analyzed at the beginning of the follow-up, and,
although no significant differences were found between them
in both groups of patients, other factors not included in
the initial evaluation or changes in the parameters included
could have taken part in glaucoma progression. In addition,
glaucoma is a chronic disease with a long period of evolution,
for which the follow-up that has been used in this study is a
period that allows us to extract initial conclusions, to detect
design mistakes and to raise new hypotheses, though it is not
still long enough to assume etiopathogenic correlations and
long-term predictions.
Although the initial patient selection (patients with nor-
mal VF and glaucoma risk factors or patients with slightly
altered VF) allowed us to orient the results to early glaucoma
diagnosis focusing on glaucoma progression, these aspects
could have some limitations, such as the potential inclusion
of patients with normal tension glaucoma (NTG) in the same
category as normal subjects with asymmetric discs. For this
reason, we performed another analysis by dividing patients
according to the perimetry, IOP, and ONH aspects. In this
analysis, the CDI characteristics differed between groups,
with larger flow velocities and smaller resistance indices in
the group that included patients with normal perimetry and
normal intraocular pressure but with glaucomatous ONH
compared with those with only perimetric glaucoma or the
whole study population.This could be due, at least in part, to
the potential association of perimetric damage with smaller
Doppler velocities in all orbital vessels studied, although
the differences were not significant. Additional studies with
larger groups of patients are needed to evaluate this tendency.
Another potential limitation of the study is the absence of
a control group of totally normal subjects.
In conclusion, our work suggests that orbital hemody-
namics studied by CDI may be useful as a biomarker to
predict glaucoma progression, especially in OA and CRA
whose LDFs reached high specificities. Further studies with
a larger population are needed. An effort should be made by
researchers to determine uniformmethodologic standards of
orbital Doppler US, in order to be able to compare results.
Practical Applications. As retrobulbar hemodynamic alter-
ation might represent a risk factor for glaucoma progression
even in an early stage, when visual field is still normal and
when a classical risk factor as IOP is not altered, orbital
CDI would constitute an important diagnosis method, whose
results could help to adoptmore or less aggressive therapeutic
measures in conflicted cases.
Further Doppler studies are needed to determine the
extent to which the parameters can detect glaucoma in early
stages of the disease or to monitor treatment effectiveness.
Doppler measurements in glaucoma can be useful in com-
bination with other parameters and clinical explorations.
Disclosure
The study was conducted at Miguel Servet University Hospi-
tal.
References
[1] D. G. Bedi, D. S. Gombos, C. S. Ng, and S. Singh, “Sonography
of the eye,” American Journal of Roentgenology, vol. 187, no. 4,
pp. 1061–1072, 2006.
[2] L. M. Scoutt, M. L. Zawin, and K. J. Taylor, “Doppler US. Part I.
Basic principles, instrumentation, and pitfalls,” Radiology, vol.
174, no. 2, pp. 297–307, 1990.
[3] L. Bonomi, G. Marchini, M. Marraffa, P. Bernardi, R. Morbio,
and A. Varotto, “Vascular risk factors for primary open angle
glaucoma:The Egna-Neumarkt Study,”Ophthalmology, vol. 107,
no. 7, pp. 1287–1293, 2000.
[4] J. Flammer, S. Orgu¨l, V. P. Costa et al., “The impact of ocular
blood flow in glaucoma,” Progress in Retinal and Eye Research,
vol. 21, no. 4, pp. 359–393, 2002.
[5] R. D. Fechtner and R. N. Weinreb, “Mechanisms of optic nerve
damage in primary open angle glaucoma,” Survey of Ophthal-
mology, vol. 39, no. 1, pp. 23–42, 1994.
10 BioMed Research International
[6] S. Resnikoff, D. Pascolini, D. Etya’ale et al., “Global data on
visual impairment in the year 2002,”Bulletin of theWorldHealth
Organization, vol. 82, no. 11, pp. 844–851, 2004.
[7] H. A. Quigley and A. T. Broman, “The number of people with
glaucoma worldwide in 2010 and 2020,” British Journal of Oph-
thalmology, vol. 90, no. 3, pp. 262–267, 2006.
[8] A. Tuulonen, J. Lehtola, and P. J. Airaksinen, “Nerve fiber layer
defects with normal visual fields: do normal optic disc and nor-
mal visual field indicate absence of glaucomatous abnormality?”
Ophthalmology, vol. 100, no. 5, pp. 587–598, 1993.
[9] T. G. Zeyen and J. Caprioli, “Progression of disc and field
damage in early glaucoma,” Archives of Ophthalmology, vol. 111,
no. 1, pp. 62–65, 1993.
[10] S. S. Hayreh, I. H. Revie, and J. Edwards, “Vasogenic origin of
visual field defects and optic nerve changes in glaucoma,”British
Journal of Ophthalmology, vol. 54, no. 7, pp. 461–472, 1970.
[11] K. Yaoeda, M. Shirakashi, A. Fukushima et al., “Relationship
between optic nerve head microcirculation and visual field loss
in glaucoma,”Acta Ophthalmologica Scandinavica, vol. 81, no. 3,
pp. 253–259, 2003.
[12] N. Plange, M. Kaup, A. Weber, A. Harris, K. O. Arend, and A.
Remky, “Performance of colour Doppler imaging discriminat-
ing normal tension glaucoma from healthy eyes,” Eye, vol. 23,
no. 1, pp. 164–170, 2009.
[13] N. Akcar, N. Yildirim, B. Adapinar, T. Kaya, and I. R. Ozkan,
“Duplex sonography of retro-orbital and carotid arteries in
patients with normal-tension glaucoma,” Journal of Clinical
Ultrasound, vol. 33, no. 6, pp. 270–276, 2005.
[14] A.Harris,H. S. Chung, T.A.Ciulla, and L.Kagemann, “Progress
in measurement of ocular blood flow and relevance to our
understanding of glaucoma and age-related macular degener-
ation,” Progress in Retinal and Eye Research, vol. 18, no. 5, pp.
669–687, 1999.
[15] N. Plange, M. Kaup, O. Arend, and A. Remky, “Asymmetric
visual field loss and retrobulbar haemodynamics in primary
open-angle glaucoma,” Graefe’s Archive for Clinical and Exper-
imental Ophthalmology, vol. 244, no. 8, pp. 978–983, 2006.
[16] F. Galassi, A. Sodi, F. Ucci, G. Renieri, B. Pieri, and M. Baccini,
“Ocular hemodynamics and glaucoma prognosis: A Color
Doppler Imaging Study,”Archives of Ophthalmology, vol. 121, no.
12, pp. 1711–1715, 2003.
[17] A. Martinez and M. Sanchez, “Ocular haemodynamics in
pseudoexfoliative and primary open-angle glaucoma,” Eye, vol.
22, no. 4, pp. 515–520, 2008.
[18] P. Calvo, A. Ferreras, V. Polo et al., “Predictive value of retrobul-
bar blood flow parameters in glaucoma suspects,” Investigative
Ophthalmology & Visual Science , vol. 53, no. 7, pp. 3875–3884,
2012.
[19] O. Zeitz, P. Galambos, L. Wagenfeld et al., “Glaucoma progres-
sion is associated with decreased blood flow velocities in the
short posterior ciliary artery,” British Journal of Ophthalmology,
vol. 90, no. 10, pp. 1245–1248, 2006.
[20] A. Mart´ınez and M. Sa´nchez, “Predictive value of colour
Doppler imaging in a prospective study of visual field progres-
sion in primary open-angle glaucoma,” Acta Ophthalmologica
Scandinavica, vol. 83, no. 6, pp. 716–722, 2005.
[21] E. Hodapp, R. K. Parrish, andD. R. Anderson,Clinical Decisions
in Glaucoma, The CVMosby, St Louis, Mo, USA, 1993.
[22] G. Wollstein, D. F. Garway-Heath, and R. A. Hitchings, “Iden-
tification of early glaucoma cases with the scanning laser
ophthalmoscope,”Ophthalmology, vol. 105, no. 8, pp. 1557–1563,
1998.
[23] A. Ferreras, A. B. Pajar´ın, V. Polo, J. M. Larrosa, L. E. Pablo,
and F. M. Honrubia, “Diagnostic ability of heidelberg retina
tomograph 3 classifications: glaucoma probability score versus
moorfields regression analysis,” Ophthalmology, vol. 114, no. 11,
pp. 1981.e1–1987.e1, 2007.
[24] E. J. Boote, “Doppler US techniques: concepts of blood flow
detection and flow dynamics,” Radiographics, vol. 23, no. 5, pp.
1315–1327, 2003.
[25] T. H. Williamson and A. Harris, “Ocular blood flow measure-
ment,” British Journal of Ophthalmology, vol. 78, no. 12, pp. 939–
945, 1994.
[26] D. S. Kamal, D. F. Garway-Heath, R. A. Hitchings, and F. W.
Fitzke, “Use of sequential Heidelberg retina tomograph images
to identify changes at the optic disc in ocular hypertensive
patients at risk of developing glaucoma,” British Journal of
Ophthalmology, vol. 84, no. 9, pp. 993–998, 2000.
[27] L. M. Zangwill, R. N. Weinreb, J. A. Beiser et al., “Baseline
topographic optic disc measurements are associated with the
development of primary open-angle glaucoma: the Confocal
Scanning Laser Ophthalmoscopy Ancillary Study to the Ocular
Hypertension Treatment Study,”Archives of Ophthalmology, vol.
123, no. 9, pp. 1188–1197, 2005.
[28] S. Miglior, M. Guareschi, E. Albe’, S. Gomarasca, M. Vavas-
sori, and N. Orzalesi, “Detection of glaucomatous visual field
changes using the Moorfields regression analysis of the Hei-
delberg retina tomograph,”American Journal of Ophthalmology,
vol. 136, no. 1, pp. 26–33, 2003.
[29] A. Heijl, M. C. Leske, B. Bengtsson, L. Hyman, B. Bengtsson,
and M. Hussein, “Reduction of intraocular pressure and glau-
coma progression: results from the early manifest glaucoma
trial,” Archives of Ophthalmology, vol. 120, no. 10, pp. 1268–1279,
2002.
[30] M. C. Leske, A. Heijl, L. Hyman, B. Bengtsson, L. Dong, and Z.
Yang, “Predictors of long-termprogression in the earlymanifest
glaucoma trial,” Ophthalmology, vol. 114, no. 11, pp. 1965–1972,
2007.
[31] R. S. Harwerth, L. Carter-Dawson, F. Shen, E. L. Smith III, and
M. L. J. Crawford, “Ganglion cell losses underlying visual field
defects from experimental glaucoma,” InvestigativeOphthalmol-
ogy and Visual Science, vol. 40, no. 10, pp. 2242–2250, 1999.
[32] B. C. Chauhan, T. A. McCormick, M. T. Nicolela, and R. P.
LeBlanc, “Optic disc and visual field changes in a prospective
longitudinal study of patients with glaucoma: comparison of
scanning laser tomography with conventional perimetry and
optic disc photography,”Archives of Ophthalmology, vol. 119, no.
10, pp. 1492–1499, 2001.
[33] C. A. Johnson, P. A. Sample, L.M. Zangwill et al., “Structure and
function evaluation (SAFE): II. Comparison of optic disk and
visual field characteristics,”American Journal of Ophthalmology,
vol. 135, no. 2, pp. 148–154, 2003.
[34] F. A. Medeiros, L. M. Zangwill, C. Bowd, and R. N. Weinreb,
“Comparison of theGDxVCC scanning laser polarimeter, HRT
II confocal scanning laser ophthalmoscope, and stratus OCT
optical coherence tomograph for the detection of glaucoma,”
Archives of Ophthalmology, vol. 122, no. 6, pp. 827–837, 2004.
[35] A. Ferreras, L. E. Pablo, D. F. Garway-Heath, P. Fogagnolo, and J.
Garc´ıa-Feijoo, “Mapping standard automated perimetry to the
peripapillary retinal nerve fiber layer in glaucoma,” Investigative
Ophthalmology and Visual Science, vol. 49, no. 7, pp. 3018–3025,
2008.
[36] S. J. A. Rankin, B. E. Walman, A. R. Buckley, and S. M. Drance,
“Color Doppler imaging and spectral analysis of the optic nerve
BioMed Research International 11
vasculature in glaucoma,” American Journal of Ophthalmology,
vol. 119, no. 6, pp. 685–693, 1995.
[37] M. T. Nicolela, S. M. Drance, S. J. A. Rankin, A. R. Buckley,
and B. E. Walman, “Color Doppler imaging in patients with
asymmetric glaucoma and unilateral visual field loss,”American
Journal of Ophthalmology, vol. 121, no. 5, pp. 502–510, 1996.
[38] H. J. Kaiser, A. Schoetzau, D. Stu¨mpfig, and J. Flammer, “Blood-
flow velocities of the extraocular vessels in patients with high-
tension and normal-tension primary open-angle glaucoma,”
American Journal of Ophthalmology, vol. 123, no. 3, pp. 320–327,
1997.
[39] H. Birinci, M. Danaci, I. Oge, and N. D. Erkan, “Ocular blood
flow in healthy and primary open-angle glaucomatous eyes,”
Ophthalmologica, vol. 216, no. 6, pp. 434–437, 2002.
[40] J. Neme´th, R. Kova´cs, Z. Harka´nyi, K. Kne´zy, K. Se´nyi, and I.
Marsovszky, “Observer experience improves reproducibility of
color Doppler sonography of orbital blood vessels,” Journal of
Clinical Ultrasound, vol. 30, pp. 332–335, 2002.
[41] A. Harris, T. H. Williamson, B. Martin et al., “Test/retest repro-
ducibility of color Doppler imaging assessment of blood flow
velocity in orbital vessels,” Journal of Glaucoma, vol. 4, no. 4,
pp. 281–286, 1995.
[42] G. K. Kouvidis, A. Benos, G. Kyriakopoulou, G. Anastopoulos,
and D. Triantafyllou, “Colour Doppler ultrasonography of the
ophthalmic artery: flow parameters in normal subjects,” Inter-
national Angiology, vol. 19, no. 4, pp. 319–325, 2000.
Submit your manuscripts at
http://www.hindawi.com
Stem Cells
International
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
MEDIATORS
INFLAMMATION
of
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Behavioural 
Neurology
Endocrinology
International Journal of
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Disease Markers
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
BioMed 
Research International
Oncology
Journal of
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Oxidative Medicine and 
Cellular Longevity
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
PPAR Research
The Scientific 
World Journal
Hindawi Publishing Corporation 
http://www.hindawi.com Volume 2014
Immunology Research
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Journal of
Obesity
Journal of
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
 Computational and  
Mathematical Methods 
in Medicine
Ophthalmology
Journal of
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Diabetes Research
Journal of
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Research and Treatment
AIDS
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Gastroenterology 
Research and Practice
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Parkinson’s 
Disease
Evidence-Based 
Complementary and 
Alternative Medicine
Volume 2014
Hindawi Publishing Corporation
http://www.hindawi.com
